Januvia

Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Bloomberg
Fri, 07/26/13 - 09:03 am
diabetes
Europe
Byetta
Bristol-Myers Squibb
Merck
Januvia
GLP-1 agonist
Novo Nordisk
Victoza
Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
Seeking Alpha
Wed, 07/10/13 - 10:25 am
Merck
diabetes
Novo Nordisk
Eli Lilly
Novartis
Januvia
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
India's top court rebuffs Merck, lets generic Januvia roll out
Fierce Pharma
Fri, 04/5/13 - 11:42 am
India
Merck
Januvia
diabetes
generics
Glenmark
Johnson & Johnson's New Diabetes Drug And Its Competitors
Seeking Alpha
Tue, 04/2/13 - 09:52 am
JNJ
diabetes
Invokana
Merck
Januvia
Byetta
Bristol-Myers Squibb
Is Merck's Type 2 Diabetes Blockbuster in Trouble?
Motley Fool
Wed, 03/27/13 - 09:54 am
Merck
Januvia
diabetes
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Bloomberg
Tue, 02/26/13 - 10:04 am
Merck
diabetes
Bristol-Myers Squibb
pancreatitis
Januvia
Byetta
Merck's Dynamic Duo
Motley Fool
Fri, 02/15/13 - 10:42 am
Merck
Januvia
Janumet
diabetes
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wed, 02/6/13 - 08:34 am
diabetes
Merck
SGLT2 inhibitor
Bristol-Myers Squibb
AstraZeneca
JNJ
Array Biopharma
Januvia
Amgen
Forixga
GKAs
Merck ceases diabetes-cholesterol pill development
Marketwatch
Tue, 11/13/12 - 11:47 am
MK-0524B
MK-0431E
diabetes
Januvia
Merck
Extending the Diabetes Dominance
Motley Fool
Sat, 10/6/12 - 11:49 am
Merck
MK-3102
Januvia
diabetes
type 2 diabetes
Merck: The Januvia Surge
Seeking Alpha
Tue, 09/11/12 - 11:56 am
Januvia
Merck
diabetes
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tue, 08/28/12 - 10:54 am
Merck
Januvia
diabetes
AstraZeneca
Bristol-Myers Squibb
JNJ
Novartis
Sanofi
Takeda
Alexion's Soliris to Merck's Januvia, top 20 generate huge growth
Fierce Pharma
Fri, 08/10/12 - 06:31 pm
Merck
Alexion
Soliris
Januvia
J&J diabetes drug tops older therapies in studies
Reuters
Sat, 06/9/12 - 12:42 pm
JNJ
diabetes
canagliflozin
type 2 diabetes
Januvia
Merck
J&J Diabetes Drug Seen Challenging Merck’s Market Leader
Bloomberg
Fri, 06/8/12 - 09:44 am
JNJ
diabetes
Merck
canagliflozin
Januvia
Merck CEO assures shareholders there is life after death of Singulair patent
Fierce Pharma
Wed, 05/23/12 - 12:32 pm
Singulair
patents
Merck
Pharma CEOs
Kenneth Frazier
Januvia
Victrelis

Pages